Results 241 to 250 of about 110,979 (314)
This is the first randomised placebo‐controlled trial of intralymphatic immunotherapy using a microcrystalline tyrosine‐adjuvanted grass pollen allergoid. Three ultrasound‐guided ILIT injections were well tolerated and reduced combined symptom‐medication scores compared with placebo. The findings support further optimisation and clinical development of
Lara Šošić +13 more
wiley +1 more source
MicroRNAs as current diagnostic biomarkers and potential therapeutic targets in allergic and non-allergic rhinitis - A functional characterization. [PDF]
Przychodniak D +2 more
europepmc +1 more source
ABSTRACT Aim To evaluate the association between reported symptoms upon exposure to airborne allergens and sensitization to the corresponding allergen. Method In a population‐based cohort, 1647 children aged 12 years were interviewed about symptoms from eyes, nose and lower airways upon exposure to birch, timothy, cat, dog, and horse, and were ...
E. Rönmark +5 more
wiley +1 more source
Real‐World Evaluation of AI‐Assisted Readout of Skin Prick Automated Test Results
Allergy, EarlyView.
Julie van Waterschoot +36 more
wiley +1 more source
Among 211 prospectively followed Swiss patients with eosinophilic oesophagitis, chronic rhinosinusitis was two‐ to three‐fold more common than in the general population. It was associated with greater oesophageal symptom severity and, in a quarter of cases, was experienced by patients as more debilitating than the underlying oesophageal disease ...
Gebhardt Aidan +52 more
wiley +1 more source
Potential of real-time pollen data: perceived needs and symptom management among seasonal allergic rhinitis patients. [PDF]
van Gaal N +3 more
europepmc +1 more source
Objective To report 45 cases of melioidosis in dogs and cats from northern Australia and analyse trends in epidemiology, clinical presentation, pathogenesis and response to treatment over a 27‐year period. Design Retrospective and prospective analysis of clinical records.
K Lee +6 more
wiley +1 more source
Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study. [PDF]
Li L, Xu Y, Bian S, Pan Z, Guan K.
europepmc +1 more source
Association of the CD14 gene rs2569190 polymorphism with the risk of allergic rhinitis: a systematic review and meta-analysis. [PDF]
Xiao Y, Mei X, Hou Q.
europepmc +1 more source

